Source: Fierce Biotech A report out this week by PwC thinks biotech could be in for a good year for deals as it sees the momentum from 2019 growing, although don’t expect many mega-deals. In the final year of the decade, a new report out called "Global Pharma & Life Sciences deals…...

Source: FierceBiotech Dermatology player Arcutis Biotherapeutics set up shop in 2016 but stayed under the radar until early last year. Now, with a trio of clinical-stage programs and more than $160 million in the bank, the company is looking to hit the street with a $100 million IPO. The Los…...